n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide has been researched along with fura-2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sharp, GW; Yaney, GC | 1 |
Barraquer, R; Gual, A; Llobet, A; Nicolás, JM; Palés, J; Tobías, E | 1 |
2 other study(ies) available for n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and fura-2
Article | Year |
---|---|
Calmodulin and insulin secretion: use of naphthalenesulfonamide compounds.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calmodulin; Cell Line; Fura-2; In Vitro Techniques; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Male; Pancreatic Neoplasms; Rats; Rats, Inbred Strains; Sulfonamides | 1990 |
Bradykinin decreases outflow facility in perfused anterior segments and induces shape changes in passaged BTM cells in vitro.
Topics: Aged; Aged, 80 and over; Animals; Aqueous Humor; Bradykinin; Bradykinin Receptor Antagonists; Calcium; Calmodulin; Cattle; Cell Size; Cells, Cultured; Fura-2; Humans; Perfusion; Sulfonamides; Trabecular Meshwork | 1999 |